Extrusion-spheronisation of highly loaded 5-ASA multiparticulate dosage forms

International Journal of Pharmaceutics

Volumn 402, Issue 1-2, 2010, Pages 153-164

  Di Pretoro, G ^a   Zema, L ^a   Gazzaniga, A ^a   Rough, S L ^b   Wilson, D I ^b  

^a Dipartimento di Scienze Farmaceutiche P Pratesi   (Italy)

^b New Museums Site ^*  (United Kingdom)

Author keywords

5 Aminosalicylic acid; Granulation; Liquid phase migration; Microcrystalline cellulose; Ram extrusion

Indexed keywords

AVICEL CL611; MESALAZINE; MICROCRYSTALLINE CELLULOSE; UNCLASSIFIED DRUG;

ARTICLE; DRUG DOSAGE FORM; DRUG MANUFACTURE; PARTICLE SIZE; PELLET EXTRUSION; PRIORITY JOURNAL; REPRODUCIBILITY; SPHERONIZATION; WATER CONTENT;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLULOSE; EXCIPIENTS; HYDROGEN-ION CONCENTRATION; MESALAMINE; PARTICLE SIZE; REPRODUCIBILITY OF RESULTS; WATER;

EID: 78349303901     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.10.003     Document Type: Article

References (30)

1. Allgayer H., Sonnenbichler J., Kruis W., Paumgartner G. Determination of the pK values of 5-aminosalicylic acid and N-acetylaminosalicylic acid and comparison of the pH dependent lipid-water partition coefficients of sulphasalazine and its metabolites. Arzneimittelforschung 1985, 35:1457-1459.
2. Bechgaard H., Hagermann N.G. Controlled-release multi-units and single unit doses. A literature review. Drug Dev. Ind. Pharm. 1978, 4:53-67.
3. Bains D., Boutell S.L., Newton J.M. The influence of moisture content on the preparation of spherical granules of barium sulphate and microcrystalline cellulose. Int. J. Pharm. 1991, 69:233-237.
4. Buckland A., Bodger K. The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis. Aliment. Pharmacol. Ther. 2008, 28:1287-1296.
5. Cervený P., Bortlík M., Kubena A., Vlcek J., Lakatos P.L., Lukás M. Nonadherence in inflammatory bowel disease: results of factor analysis. Inflamm. Bowel Dis. 2007, 13:1244-1249.
6. Chuong M.C., Christensen J.M., Ayres J.W. Sustained delivery of intact drug to the colon: mesalamine formulation and temporal gastrointestinal transit analysis. Pharm. Dev. Technol. 2008, iFirst:1-10. 10.1080/10837450802420559.
7. Cohen R.D. Review article: evolutionary advances in the delivery of aminosalicylates for the treatment of ulcerative colitis. Aliment. Pharmacol. Ther. 2006, 24:465-474.
8. Fielden K.E., Newton J.M., O'Brien P., Rowe R.C. Thermal studies on the interaction of water and microcrystalline cellulose. J. Pharm. Pharmacol. 1988, 40:674-678.
9. Fielden K.E., Newton J.M., Rowe R.C. The influence of lactose particle size on spheronization of extrudate processed by a ram extruder. Int. J. Pharm. 1992, 81:205-224.
10. Gazzaniga A., Sangalli M.E., Bruni G., Zema L., Vecchio C., Giordano F. The use of β-cyclodextrin as a pelletization agent in the extrusion/spheronization process. Drug Dev. Ind. Pharm. 1998, 24:869-873.
11. Goskonda S.R., Hileman G.A., Upadrashta S.M. Development of matrix controlled release beads by extrusion-spheronization technology using a statistical screening design. Drug Dev. Ind. Pharm. 1994, 20:279-292.
12. Hagsten A., Casper Larsen C., Møller Sonnergaard J., Rantanen J., Hovgaard L. Identifying sources of batch to batch variation in processability. Powder Technol. 2008, 183:213-219.
13. Harrison P.J., Newton J.M., Rowe R.C. The characterisation of wet powder masses suitable for extrusion/spheronisation. J. Pharm. Pharmacol. 1985, 37:686-691.
14. Hassler G.L., Brunner E. Measurement of capillary pressures in small core samples. Trans. AIMechE 1945, 160:114-123.
15. Hileman G.A., Goskonda S.R., Spalitto A.J., Upadrashta S.M. A factorial approach to high dose product development by an extrusion/spheronization process. Drug Dev. Ind. Pharm. 1993, 19:483-491.
16. Kraeger J.S., Edge S., Price R. Influence of particle size and shape on flowability and compactibility of binary mixtures of paracetamol and microcrystalline cellulose. Eur. J. Pharm. Sci. 2004, 22:173-179.
17. Krieger M., Dougherty J. A mechanism for non-Newtonian flow in suspensions of rigid spheres. J. Rheol. 1959, 3:137-152.
18. Latimer P., Brunsting A., Pyle B.E., Moore C. Effects of asphericity on single particle scattering. Appl. Opt. 1978, 17:3152-3158.
19. Mascia S., Patel M.J., Rough S.L., Martin P.J., Wilson D.I. Liquid phase migration in the extrusion and squeezing of microcrystalline cellulose pastes. Eur. J. Pharm. Sci. 2006, 29:22-34.
20. O'Connor R.E., Holinej J., Schwartz J.B. Spheronization I: processing and evaluation of spheres prepared from commercially available excipients. Am. J. Pharm. 1984, 156:80-87.
21. Podczeck F., Knight P. The evaluation of formulations for the preparation of pellets with high drug loading by extrusion/spheronization. Pharm. Dev. Technol. 2006, 11:263-274.
22. Podczeck F., Knight P.E., Newton J.M. The evaluation of modified microcrystalline cellulose for the preparation of pellets with high drug loading by extrusion/spheronization. Int. J. Pharm. 2007, 350:145-154.
23. Rough S.L., Bridgwater J., Wilson D.I. Effects of liquid phase migration on extrusion of microcrystalline cellulose pastes. Int. J. Pharm. 2000, 204:117-126.
24. Rough S.L., Wilson D.I., Bridgwater J. A model describing liquid phase migration within an extruding microcrystalline cellulose paste. Chem. Eng. Res. Des. 2002, 80:701-714.
25. Rough S.L., Wilson D.I. Extrudate fracture and spheronisation of microcrystalline cellulose pastes. J. Mater. Sci. 2005, 40:4199-4219.
26. Rudolph M.W., Klein S., Beckert T.E., Petereit H.-U., Dressman J.B. A new 5-aminosalicylic acid multi-unit dosage form for the therapy of ulcerative colitis. Eur. J. Pharm. Biopharm. 2001, 51:183-190.
27. Tomer G., Podczeck F., Newton J.M. The influence of type and quantity of model drug on the extrusion/spheronization of mixtures with microcrystalline cellulose. I: Extrusion parameters. Int. J. Pharm. 2001, 217:237-248.
28. Tomer G., Podczeck F., Newton J.M. The influence of model drugs on the preparation of pellets by extrusion/spheronization. II: Spheronization parameters. Int. J. Pharm. 2002, 231:107-119.
29. Vervaet C., Baert L., Remon J.P. Extrusion-spheronisation. A literature review. Int. J. Pharm. 1995, 116:131-146.
30. Wei H.E., Fan L.-F., Min B., Yong-Zhen C., Bai S X., Qing D., Feng W., Min Q., De-Ying C. Chitosan/kollicoat SR 30D film-coated pellets of aminosalicylates for colonic drug delivery. J. Pharm. Sci. 2010, 99:186-195.